Navigation Links
Thou shalt not live on 'white' bread alone

Let those who have a craving for white bread pause to hear this. New reports show ample proof that goes to prove that excessive consumption of white bread could lead to cancer of the kidneys. //

White bread is made of refined flour. Researchers have come to conclusion that use of excessive refined flour in ones diet can supply surplus of sugar to the circulation which in turn stimulates the release of insulin into the blood stream which is understood to be viable reasons for triggering of cancerous growths in ones body. Those who eat more than 5 slices of white bread a day stand more chances of developing renal carcinoma than those who restrict their intake to about one and half slices a day.

Dr Francesca Bravi, from the Institute of Pharmacological Research in Milan, Italy, in her course of study has shown that a diet rich in whole grain cereals and with generous portions of vegetables can reduce the prospects of developing renal cancer among high risk groups.

Even other health experts have warned people about the hazards associated with excessive intake of white bread.


MST
'"/>




Page: 1

Related medicine news :

1. A drive to fortify bread with folic acid
2. Include folic acid in bread to reduce neural tube defects in new borns
3. Living alone is a deterrent to good health
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Thou shalt not live white bread alone

(Date:8/29/2008)...l., Aug. 29 /PRNewswire-FirstCall/ -- Landauer, In...irectors declared a regular,quarterly cash dividen...cal,2008. The dividend will be paid on October 3, ...008., About Landauer, Landauer is the leading pr...ional and environmental radiation exposure. For mo...
(Date:8/29/2008)... AMD presents Telemedicine Encounter Mana... State delegations as a possible solution to natio... N.Chelmsford, MA (PRWEB) August 29, 2008 -- If ...by the speakers at the Democratic National Convent...esolve our national health care issues., , ,Our De...
(Date:8/28/2008)...with person with dementia led to daytime tiredness...ug. 28 (HealthDay News) -- Older adults who live w...omeone with dementia have significantly worse slee..., The study compared 31 caregivers and 102 nonc...3 minutes less per night than non-caregivers and t...
(Date:8/28/2008)...f., Aug. 28 /PRNewswire-FirstCall/ -- ISTA Pharmac...t will present at the Thomas Weisel,Partners Healt...rsday,September 4, 2008 at the Four Seasons Hotel...tive Officer, Vicente Anido, Jr.,Ph.D., will prov...ical,progress. To access the live audio broadcast ...
Breaking Medicine News(10 mins):Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Older Caregivers Prone to Worse Sleep Patterns 2
Plump Infants Getting Obese Later In Life In More Cases
...ound that there is no link whatsoever between brea...atins or lipid lowering drugs //to control the sam...October 24 issue of Archives of Internal Medicine,... article says that although some evidence has been...
... likely to invoke the compulsory licensing (CL) pr...tic drug //firms to produce and stockpile Swiss dr...combating the global threat against the most dread...ers the government to issue CL without receipt of ...
...ial lung disease (ILD) comprises a large, heteroge...rized by diffuse infiltrates, restrictive lung dis...mortality and morbidity. ILD presents enormous dia...ial diagnosis includes more than 100 conditions in...
Other Medicine News:Health News:A New Diagnostic Approach To Pediatric Interstitial Lung Disease 2
(Date:8/28/2008)... to collaborate on studies of immunosuppression ...diated immunity, COLUMBIA, Md., Aug. 28 /PRNewswi...n distributor, Sun Woo Biotech, is delighted to be...enter trial of the ImmuKnow assay,for cell-mediate...tutions,in the Republic of Korea," stated Brad Ste...
(Date:8/28/2008)... /- Intercell AG (VSE: ICLL) today,an...s initiated a Phase II,clinical trial of V710, an ...hylococcus aureus (S. aureus) infections. This ran...s to evaluate the safety and immunogenicity of,the...ey disease on,hemodialysis. This trial start follo...
(Date:8/27/2008)...in Parts of Bucks, Delaware, Montgomery,Philadelp...e-USNewswire/ -- After encouraging,results followi...tment of,Environmental Protection will continue it...st the mosquito-borne West Nile virus., Targeted ....m. and,midnight in portions of Bucks, Delaware, M...
(Date:8/27/2008)..., melphalan and prednisone arm demonstrated a, si... complete response -, CAMBRIDGE, Mass., Aug. 27 /...pany today announced the publication of results fr... trial in this week,s edition of the,New England J...nt survival,benefit and a 30 percent complete remi...
Breaking Medicine Technology:Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea 2Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea 3Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6State of Arkansas Department of Human Services Division of Medical Services Selects U S Care Management for High Risk Obstetrics Health Management P 6752 1State of Arkansas Department of Human Services Division of Medical Services Selects U S Care Management for High Risk Obstetrics Health Management P 6752 2State of Arkansas Department of Human Services Division of Medical Services Selects U S Care Management for High Risk Obstetrics Health Management P 6752 3State of Arkansas Department of Human Services Division of Medical Services Selects U S Care Management for High Risk Obstetrics Health Management P 6752 4CardioMag Announces Results of 2006 Annual Shareholders Meeting and Board Meeting 1885 1CardioMag Announces Results of 2006 Annual Shareholders Meeting and Board Meeting 1885 2Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 1881 1Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 1881 2Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 1881 3Penn researchers find monkeys able to fend off AIDS like symptoms with enhanced HIV vaccine 1293 1Penn researchers find monkeys able to fend off AIDS like symptoms with enhanced HIV vaccine 1293 2
...ncer Conference, NORTH HOLLYWOOD, Calif., and CHIC...al Myeloma Foundation (IMF)-supporting research,an...eloma patients,families, researchers and physicia...e 3 multi- national clinical trial shows the,combi...obability of,survival by 41%. The follow-up study ...
...ity Support Development of Panzem(R),NCD as a Comb...ILLE, Md., June 05, 2007 /PRNewswire-FirstCall/ --...company developing,therapeutics for the treatment ... presentation of results of a single-agent Phase 2...lioblastoma,multiforme (GBM). The data were presen...
Other Medicine Technology:Study Shows Velcade Plus Doxil Improves Survival in Previously,Treated Patients With Multiple Myeloma 2Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 2Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 3Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 4
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
Medicine Products: